Celldex (CLDX) Gains after Abstract Published

September 28, 2016 8:33 AM EDT
Get Alerts CLDX Hot Sheet
Trade CLDX Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Celldex (NASDAQ: CLDX) is adding to yesterday's gain after an ESMO abstract on glembatumumab vedotin was published. Also the company is presenting at the Leerink conference on Thursday.

Shares of CLDX are up 3.6% after gaining 11.2% yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk

Add Your Comment